TABLE 2.
Putative metabolites produced at 37°C identified by the auxiliary method
| XIC ID | Regulation | Treatment | Log2 fold change | Putative metabolite ID | KEGG ID/Lipid Maps ID |
|---|---|---|---|---|---|
| 10 | Up | C16:0 sLCOs | 1.06 | 6′-Hydroxysiphonaxanthin decenoate | LMPR01070951 |
| 12 | Up | C16:0 sLCOs | 1.07 | Unknown | |
| 44 | Up | C16:0 nsLCOs | 1.82 | Burseran | C10547 |
| 44 | Up | C18:1 nsLCOs | 1.52 | Burseran | C10547 |
| 44 | Up | C18:1 sLCOs | 1.61 | Burseran | C10547 |
| 44 | Up | C16:0 sLCOs | 1.66 | Burseran | C10547 |
| 70 | Up | C18:1 sLCOs | 1.13 | 4′-O-desmethyl-3-O-acetylpapaveroxine | C21590 |
| 73 | Up | C18:1 sLCOs | 2.11 | Alprazolam | C06817 |
| 93 | Up | C18:1 nsLCOs | 1.15 | Unknown | |
| 93 | Up | C18:1 sLCOs | 1.03 | Unknown | |
| 114 | Up | C16:0 nsLCOs | 1.54 | Clofibrate | C06916 |
| 114 | Up | C18:1 nsLCOs | 1.27 | Clofibrate | C06916 |
| 114 | Up | C18:1 sLCOs | 2.36 | Clofibrate | C06916 |
| 119 | Up | C16:0 nsLCOs | 1.66 | Minabeolide-2 | LMST01160003 |
| 119 | Up | C18:1 nsLCOs | 1.70 | Minabeolide-2 | LMST01160003 |
| 119 | Up | C18:1 sLCOs | 1.71 | Minabeolide-2 | LMST01160003 |
| 119 | Up | C16:0 sLCOs | 1.09 | Minabeolide-2 | LMST01160003 |
| 120 | Up | C16:0 nsLCOs | 1.29 | Fumiquinazoline F | C22145 |
| 120 | Up | C18:1 nsLCOs | 1.04 | Fumiquinazoline F | C22145 |
| 120 | Up | C18:1 sLCOs | 1.42 | Fumiquinazoline F | C22145 |
| 120 | Up | C16:0 sLCOs | 1.03 | Fumiquinazoline F | C22145 |
| 121 | Up | C16:0 nsLCOs | 1.40 | Clofibrate | C06916 |
| 121 | Up | C18:1 sLCOs | 2.12 | Clofibrate | C06916 |
| 157 | Up | C16:0 nsLCOs | 1.48 | Alprazolam | C06817 |
| 157 | Up | C18:1 nsLCOs | 1.23 | Alprazolam | C06817 |
| 157 | Up | C18:1 sLCOs | 2.39 | Alprazolam | C06817 |